5-Chloropyrazolo[1,5-a]pyrimidine-3-carbaldehyde, 97%, 100mg

2'-ANILINO-6'-[ETHYL(P-TOLYL)AMINO]-3'-METHYLSPIRO[ISOBENZOFURAN-1(3H),9'-[9H]XANTHENE]-3-ONE, 95%, 1g

5-METHYL-4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-1H-INDAZOLE, 95%, 25g

(SP-4-1)-[1,3-BIs[2,6-bis(1-ethylpropyl)phenyl]-4,5-dichloro-1,3-dihydro-2H-imidazol-2-ylidene]dichloro(2-methylpyridine)palladium, 97%, 5g

4-Nitropyrrole-2-carboxylic Acid>99.0%(HPLC)(T)1g

6-amino-2-(2-aminoethyl)-3,4-dihydropyrimidin-4-one dihydrochloride, 98%, 1g

GC capillary column ROTI®Cap-5, 15 m, 0.32 mm, 5.00 µm, 1 Piece(s)

3-Formyl-4-methoxyindole, 95.0%, 25g

Di-n-butyl sulfate, 98%, 25g

Methyl 4-hydroxynicotinate, 95.0%, 5g

Ethyl 1-oxiranylmethylisonipecotate, 95.0%, 1g

N-(3-methylenecyclohexyl)-, 1,1-dimethylethyl ester, 95.0%, 500mg

2-(2-Chloro-acetylamino)-4-(2-chloro-phenyl)-thiophene-3-carboxylic acid ethyl ester, 95.0%, 2.5g